Pankaj Mohan Sonnet Bio Therapeutics Holdings, Inc. (SONN) insider trading activity

SONN Quotes by TradingView

Pankaj Mohan is Chairman, President and CEO of Sonnet BioTherapeutics Holdings, Inc.. Currently has a direct ownership of 14,987 shares of SONN, which is worth approximately $67,891. The most recent transaction as insider was on Dec 11, 2023, when has been sold 7,554 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15K
0% 3M change
0% 12M change
Total Value Held $67,891

Pankaj Mohan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 11 2023
BUY
Grant, award, or other acquisition
-
7,554 Added 33.51%
14,987 Common Stock
Oct 27 2023
BUY
Open market or private purchase
-
34,375 Added 36.61%
59,526 Common Stock
May 15 2023
BUY
Open market or private purchase
$81,752 $0.22 p/Share
371,600 Added 40.18%
553,331 Common Stock
Mar 15 2023
BUY
Open market or private purchase
$34,800 $0.58 p/Share
60,000 Added 24.82%
181,731 Common Stock
Jan 07 2023
SELL
Sale (or disposition) back to the issuer
-
73,561 Reduced 60.43%
48,170 Common Stock
Jan 07 2023
BUY
Grant, award, or other acquisition
-
73,561 Added 37.67%
121,731 Common Stock
Dec 14 2022
BUY
Grant, award, or other acquisition
-
74,205 Added 9.02%
748,606 Common Stock
Dec 15 2021
BUY
Grant, award, or other acquisition
-
320,135 Added 32.19%
674,401 Common Stock
Jun 09 2021
BUY
Open market or private purchase
$49,600 $1.55 p/Share
32,000 Added 8.28%
354,266 Common Stock
PM

Pankaj Mohan

Chairman, President and CEO
Princeton, NJ

Track Institutional and Insider Activities on SONN

Follow Sonnet BioTherapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SONN shares.

Notify only if

Insider Trading

Get notified when an Sonnet Bio Therapeutics Holdings, Inc. insider buys or sells SONN shares.

Notify only if

News

Receive news related to Sonnet BioTherapeutics Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SONN